data_1ghj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ghj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.471 -0.566 . . . . 2.27 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 2' ' ' ILE . 5.1 mt -140.48 111.45 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 2.6099999999999999 109.491 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.0 135.73 49.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 1.3999999999999999 109.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.85 110.03 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 1.9399999999999999 109.477 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -132.27 169.41 16.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 2.9900000000000002 109.488 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.57 157.18 86.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 1.25 109.493 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.06 160.5 30.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.734 2.289 . . . . 1.0900000000000001 110.415 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -73.09 115.98 13.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 2.25 109.477 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.46 149.97 86.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 2.4900000000000002 109.478 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -160.0 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.786 2.324 . . . . 1.52 110.441 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' SER . 6.7 tt0 -80.98 -55.79 4.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 3.3199999999999998 109.528 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' GLU . 15.3 t -41.31 -44.96 2.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 1.74 109.632 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.79 148.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 2.4700000000000002 109.487 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.51 10.89 7.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 1.4299999999999999 109.48 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.59 -170.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 1.3600000000000001 109.491 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.13 -171.04 21.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.541 -1.424 . . . . 0.47999999999999998 109.541 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.7 m -149.98 126.26 10.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 1.21 109.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG11 ' N ' ' A' ' 19' ' ' ALA . 38.5 t -48.22 159.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 1.1100000000000001 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 37' ' ' ASP . . . -104.22 -74.7 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 1.1200000000000001 109.46 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.0 m -160.04 132.48 6.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 1.0900000000000001 109.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.633 ' CH2' ' CD1' ' A' ' 58' ' ' ILE . 36.2 m95 -89.83 81.91 6.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.279 -0.888 . . . . 0.37 109.546 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.57 ' NE2' ' CD2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -41.36 -60.15 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.332 -0.855 . . . . 0.40000000000000002 109.535 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -103.19 -173.6 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 2.8700000000000001 109.571 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.2 mttt -128.55 169.0 13.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 2.8999999999999999 109.467 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HG3' HG12 ' A' ' 58' ' ' ILE . 35.3 Cg_endo -76.67 121.55 6.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.77 2.314 . . . . 0.58999999999999997 110.469 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.74 12.25 6.11 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.64000000000000001 109.486 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -117.43 174.8 5.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 2.98 109.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 1.3400000000000001 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.95 167.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 1.98 109.475 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 31' ' ' ARG . 4.6 tttt -138.96 127.13 22.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 3.8100000000000001 109.443 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -41.27 142.69 0.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 3.9700000000000002 109.572 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 8.3 t70 70.01 37.78 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 1.6299999999999999 109.486 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' N ' HD22 ' A' ' 48' ' ' LEU . 15.5 tt0 -133.51 113.18 12.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 2.0099999999999998 109.46 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.57 ' CD2' ' NE2' ' A' ' 22' ' ' HIS . 60.0 tp -40.42 158.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 1.25 109.685 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.489 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 10.8 mt -141.27 -41.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.943 . . . . 1.9399999999999999 109.51 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 47' ' ' VAL . 10.4 p -158.44 134.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 1.1000000000000001 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 7.3 m-20 -95.27 157.8 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 1.1100000000000001 109.463 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 79.7 mt -123.38 150.35 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 1.8600000000000001 109.446 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.0 139.4 52.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 2.0800000000000001 109.458 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER -125.83 -178.35 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 2.2799999999999998 109.459 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 40' ' ' THR . 42.9 t0 -41.4 -49.53 3.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 2.0099999999999998 109.58 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -153.22 28.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 3.1299999999999999 109.484 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.441 ' O ' ' OG1' ' A' ' 40' ' ' THR . 13.3 t -136.0 131.0 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 2.04 109.477 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -105.21 120.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 2.2200000000000002 109.491 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.7 mtt -104.7 -179.2 3.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 2.4399999999999999 109.42 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.3 147.37 41.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 1.96 109.492 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.523 ' HB ' ' CG1' ' A' ' 36' ' ' VAL . 14.7 t -118.02 101.31 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 1.3100000000000001 109.419 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.493 ' HG ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -96.02 165.85 12.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 2.4100000000000001 109.509 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 35' ' ' ILE . . . -84.65 141.32 30.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 1.3300000000000001 109.473 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -96.53 14.87 23.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 2.0099999999999998 109.484 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLU . . . 166.53 145.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 1.53 109.49 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' N ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -58.87 170.82 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 1.3300000000000001 109.671 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.55 ' N ' ' CG ' ' A' ' 52' ' ' ASP . . . 150.33 -152.99 24.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.66000000000000003 109.508 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.77 127.08 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 1.3700000000000001 109.484 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 55' ' ' ILE . 14.5 mm -59.46 163.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 1.99 109.512 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' N ' HG23 ' A' ' 55' ' ' ILE . . . -104.14 -59.62 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 1.1499999999999999 109.468 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -179.56 148.21 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 2.4100000000000001 109.485 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.633 ' CD1' ' CH2' ' A' ' 21' ' ' TRP . 22.8 mm -105.15 131.89 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 2.29 109.484 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.51 -36.28 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 1.4399999999999999 109.454 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -93.06 146.99 23.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 3.3199999999999998 109.446 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 20.5 m-80 -102.9 176.65 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 1.3500000000000001 109.522 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.69 150.03 41.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 1.95 109.514 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.67 14.7 70.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.562 -1.415 . . . . 0.88 109.562 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.562 ' CG ' ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -99.79 170.8 8.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -1.138 . . . . 1.24 109.595 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.562 ' N ' ' CG ' ' A' ' 64' ' ' ASP . 25.0 m -100.93 141.78 33.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.513 -0.742 . . . . 1.8799999999999999 109.487 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG11 ' HG2' ' A' ' 60' ' ' LYS . 15.9 m -123.57 159.98 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 1.4099999999999999 109.457 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.34 174.74 5.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 2.1499999999999999 109.495 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.7 t -68.44 115.72 8.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 1.23 109.522 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.99 24.12 36.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.528 -1.429 . . . . 0.92000000000000004 109.528 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.86 118.62 23.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -1.127 . . . . 1.6699999999999999 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 113.57 5.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 1.52 109.519 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 66' ' ' VAL . 6.9 mt -92.16 -20.64 21.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 1.6100000000000001 109.44 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.11 176.07 41.38 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.445 . . . . 0.59999999999999998 109.486 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 2.98 109.433 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tp -93.75 146.13 24.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 1.54 109.459 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 m -98.94 172.43 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 1.8300000000000001 109.438 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -60.74 -168.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 2.6200000000000001 109.473 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.97 103.37 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.41 . . . . 2.2599999999999998 109.576 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.502 -1.439 . . . . 4.0800000000000001 109.502 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.471 -0.566 . . . . 1.75 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 75' ' ' LEU . 5.1 mt -140.48 111.45 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 2.0699999999999998 109.491 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.0 135.73 49.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 1.3999999999999999 109.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.85 110.03 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 1.3500000000000001 109.477 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -132.27 169.41 16.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 2.5800000000000001 109.488 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -67.57 157.18 86.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.70999999999999996 109.493 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 35.4 Cg_endo -78.06 160.5 30.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.734 2.289 . . . . 0.97999999999999998 110.415 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -73.09 115.98 13.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 1.6699999999999999 109.477 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.46 149.97 86.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 1.5900000000000001 109.478 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -160.0 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.786 2.324 . . . . 1.3 110.441 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' SER . 6.7 tt0 -80.98 -55.79 4.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 3.3199999999999998 109.528 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' GLU . 15.3 t -41.31 -44.96 2.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 1.6499999999999999 109.632 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.66 HG22 ' H ' ' A' ' 15' ' ' ASP . 49.1 mt -101.79 148.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 1.9399999999999999 109.487 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.51 10.89 7.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.94999999999999996 109.48 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -176.59 -170.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 1.3600000000000001 109.491 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.13 -171.04 21.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.541 -1.424 . . . . 0.38 109.541 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 64' ' ' ASP . 85.7 m -149.98 126.26 10.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.53000000000000003 109.459 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 19' ' ' ALA . 38.5 t -48.22 159.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.31 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 37' ' ' ASP . . . -104.22 -74.7 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.34000000000000002 109.46 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.0 m -160.04 132.48 6.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.35999999999999999 109.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.633 ' CH2' ' CD1' ' A' ' 58' ' ' ILE . 36.2 m95 -89.83 81.91 6.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.279 -0.888 . . . . 0.34000000000000002 109.546 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.708 ' NE2' HD21 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -41.36 -60.15 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.332 -0.855 . . . . 0.40000000000000002 109.535 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -103.19 -173.6 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 2.3700000000000001 109.571 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.2 mttt -128.55 169.0 13.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 2.48 109.467 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 35.3 Cg_endo -76.67 121.55 6.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.77 2.314 . . . . 0.58999999999999997 110.469 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.74 12.25 6.11 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.64000000000000001 109.486 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -117.43 174.8 5.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 2.98 109.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.73999999999999999 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG11 HD11 ' A' ' 35' ' ' ILE . 2.3 t -112.95 167.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 1.3600000000000001 109.475 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 31' ' ' ARG . 4.6 tttt -138.96 127.13 22.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 3.3399999999999999 109.443 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -41.27 142.69 0.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 3.3700000000000001 109.572 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' C ' HD21 ' A' ' 48' ' ' LEU . 8.3 t70 70.01 37.78 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 1.6299999999999999 109.486 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 34' ' ' LEU . 15.5 tt0 -133.51 113.18 12.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 2.0099999999999998 109.46 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.708 HD21 ' NE2' ' A' ' 22' ' ' HIS . 60.0 tp -40.42 158.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.58999999999999997 109.685 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 49' ' ' ALA . 10.8 mt -141.27 -41.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.943 . . . . 1.3100000000000001 109.51 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 47' ' ' VAL . 10.4 p -158.44 134.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.45000000000000001 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 7.3 m-20 -95.27 157.8 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 1.1100000000000001 109.463 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 79.7 mt -123.38 150.35 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 1.3700000000000001 109.446 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.0 139.4 52.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 2.0800000000000001 109.458 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.499 HG22 HD13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -125.83 -178.35 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 1.73 109.459 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 40' ' ' THR . 42.9 t0 -41.4 -49.53 3.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 2.0099999999999998 109.58 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -153.22 28.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 2.6299999999999999 109.484 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -136.0 131.0 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 1.6100000000000001 109.477 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -105.21 120.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 1.6899999999999999 109.491 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.7 mtt -104.7 -179.2 3.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 1.95 109.42 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.3 147.37 41.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 1.96 109.492 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 36' ' ' VAL . 14.7 t -118.02 101.31 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.56000000000000005 109.419 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -96.02 165.85 12.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 1.8799999999999999 109.509 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 35' ' ' ILE . . . -84.65 141.32 30.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.67000000000000004 109.473 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.665 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -96.53 14.87 23.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 2.0099999999999998 109.484 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 50' ' ' GLU . . . 166.53 145.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 1.03 109.49 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' N ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -58.87 170.82 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 1.3300000000000001 109.671 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.55 ' N ' ' CG ' ' A' ' 52' ' ' ASP . . . 150.33 -152.99 24.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.66000000000000003 109.508 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.77 127.08 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.69999999999999996 109.484 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.519 HD13 HD12 ' A' ' 75' ' ' LEU . 14.5 mm -59.46 163.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 1.3300000000000001 109.512 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -104.14 -59.62 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.46999999999999997 109.468 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 25' ' ' PRO . 4.0 tt0 -179.56 148.21 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 2.4100000000000001 109.485 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.633 ' CD1' ' CH2' ' A' ' 21' ' ' TRP . 22.8 mm -105.15 131.89 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.7 109.484 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.51 -36.28 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.85999999999999999 109.454 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.585 ' HG2' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -93.06 146.99 23.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 2.9199999999999999 109.446 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 20.5 m-80 -102.9 176.65 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 1.3200000000000001 109.522 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 21' ' ' TRP . 36.0 mt-10 -73.69 150.03 41.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 1.95 109.514 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.67 14.7 70.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.562 -1.415 . . . . 0.83999999999999997 109.562 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -99.79 170.8 8.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -1.138 . . . . 1.24 109.595 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.562 ' N ' ' CG ' ' A' ' 64' ' ' ASP . 25.0 m -100.93 141.78 33.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.513 -0.742 . . . . 1.3200000000000001 109.487 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 60' ' ' LYS . 15.9 m -123.57 159.98 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.87 109.457 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.34 174.74 5.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.5800000000000001 109.495 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.7 t -68.44 115.72 8.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.89000000000000001 109.522 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.99 24.12 36.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.528 -1.429 . . . . 0.81999999999999995 109.528 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.86 118.62 23.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -1.127 . . . . 1.6699999999999999 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 113.57 5.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.93999999999999995 109.519 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mt -92.16 -20.64 21.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.93000000000000005 109.44 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.11 176.07 41.38 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.445 . . . . 0.42999999999999999 109.486 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 2.3999999999999999 109.433 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.519 HD12 HD13 ' A' ' 55' ' ' ILE . 1.1 tp -93.75 146.13 24.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.95999999999999996 109.459 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 77' ' ' GLU . 6.7 m -98.94 172.43 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 1.3 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' H ' HG22 ' A' ' 76' ' ' THR . 6.8 mt-10 -60.74 -168.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 2.6200000000000001 109.473 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.97 103.37 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.41 . . . . 2.2599999999999998 109.576 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.502 -1.439 . . . . 4.0800000000000001 109.502 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.471 -0.566 . . . . 1.75 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 75' ' ' LEU . 5.1 mt -140.48 111.45 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 2.07 109.491 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -70.0 135.73 49.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 1.4 109.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.85 110.03 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 1.35 109.477 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -132.27 169.41 16.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 2.58 109.488 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -67.57 157.18 86.84 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.71 109.493 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 35.4 Cg_endo -78.06 160.5 30.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.734 2.289 . . . . 0.98 110.415 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -73.09 115.98 13.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 1.67 109.477 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.46 149.97 86.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 1.59 109.478 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -160.0 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.786 2.324 . . . . 1.3 110.441 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' SER . 6.7 tt0 -80.98 -55.79 4.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 3.32 109.528 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' GLU . 15.3 t -41.31 -44.96 2.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 1.65 109.632 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.66 HG22 ' H ' ' A' ' 15' ' ' ASP . 49.1 mt -101.79 148.67 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 1.94 109.487 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.51 10.89 7.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.95 109.48 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -176.59 -170.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 1.36 109.491 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.13 -171.04 21.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.541 -1.424 . . . . 0.38 109.541 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 64' ' ' ASP . 85.7 m -149.98 126.26 10.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.53 109.459 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 19' ' ' ALA . 38.5 t -48.22 159.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.31 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 37' ' ' ASP . . . -104.22 -74.7 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.34 109.46 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.0 m -160.04 132.48 6.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.36 109.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.633 ' CH2' ' CD1' ' A' ' 58' ' ' ILE . 36.2 m95 -89.83 81.91 6.29 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.279 -0.888 . . . . 0.34 109.546 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.708 ' NE2' HD21 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -41.36 -60.15 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.332 -0.855 . . . . 0.4 109.535 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -103.19 -173.6 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 2.37 109.571 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 1.2 mttt -128.55 169.0 13.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 2.48 109.467 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 35.3 Cg_endo -76.67 121.55 6.0 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.77 2.314 . . . . 0.59 110.469 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.74 12.25 6.11 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.64 109.486 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -117.43 174.8 5.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -1.123 . . . . 2.98 109.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.74 109.438 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG11 HD11 ' A' ' 35' ' ' ILE . 2.3 t -112.95 167.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 1.36 109.475 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 31' ' ' ARG . 4.6 tttt -138.96 127.13 22.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 3.34 109.443 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -41.27 142.69 0.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 3.37 109.572 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' C ' HD21 ' A' ' 48' ' ' LEU . 8.3 t70 70.01 37.78 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 1.63 109.486 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 34' ' ' LEU . 15.5 tt0 -133.51 113.18 12.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 2.01 109.46 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.708 HD21 ' NE2' ' A' ' 22' ' ' HIS . 60.0 tp -40.42 158.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.59 109.685 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 49' ' ' ALA . 10.8 mt -141.27 -41.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.19 -0.943 . . . . 1.31 109.51 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 47' ' ' VAL . 10.4 p -158.44 134.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.45 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 7.3 m-20 -95.27 157.8 15.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 1.11 109.463 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 79.7 mt -123.38 150.35 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 1.37 109.446 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.0 139.4 52.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 2.08 109.458 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.499 HG22 HD13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -125.83 -178.35 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 1.73 109.459 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 40' ' ' THR . 42.9 t0 -41.4 -49.53 3.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 2.01 109.58 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -153.22 28.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 2.63 109.484 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -136.0 131.0 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 1.61 109.477 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -105.21 120.43 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 1.69 109.491 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.7 mtt -104.7 -179.2 3.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 1.95 109.42 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.3 147.37 41.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 1.96 109.492 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 36' ' ' VAL . 14.7 t -118.02 101.31 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.56 109.419 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -96.02 165.85 12.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 1.88 109.509 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 35' ' ' ILE . . . -84.65 141.32 30.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.874 . . . . 0.67 109.473 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.665 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -96.53 14.87 23.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 2.01 109.484 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 50' ' ' GLU . . . 166.53 145.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 1.03 109.49 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' N ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -58.87 170.82 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.875 . . . . 1.33 109.671 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.55 ' N ' ' CG ' ' A' ' 52' ' ' ASP . . . 150.33 -152.99 24.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.66 109.508 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.77 127.08 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.7 109.484 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.519 HD13 HD12 ' A' ' 75' ' ' LEU . 14.5 mm -59.46 163.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 1.33 109.512 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 55' ' ' ILE . . . -104.14 -59.62 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.47 109.468 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 25' ' ' PRO . 4.0 tt0 -179.56 148.21 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 2.41 109.485 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.633 ' CD1' ' CH2' ' A' ' 21' ' ' TRP . 22.8 mm -105.15 131.89 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 1.7 109.484 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.51 -36.28 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.86 109.454 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.585 ' HG2' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -93.06 146.99 23.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 2.92 109.446 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 20.5 m-80 -102.9 176.65 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 1.32 109.522 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 21' ' ' TRP . 36.0 mt-10 -73.69 150.03 41.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 1.95 109.514 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.67 14.7 70.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.562 -1.415 . . . . 0.84 109.562 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -99.79 170.8 8.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -1.138 . . . . 1.24 109.595 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.562 ' N ' ' CG ' ' A' ' 64' ' ' ASP . 25.0 m -100.93 141.78 33.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.513 -0.742 . . . . 1.32 109.487 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.585 HG12 ' HG2' ' A' ' 60' ' ' LYS . 15.9 m -123.57 159.98 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.87 109.457 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.34 174.74 5.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.58 109.495 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.7 t -68.44 115.72 8.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.89 109.522 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.99 24.12 36.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.528 -1.429 . . . . 0.82 109.528 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.86 118.62 23.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -1.127 . . . . 1.67 109.504 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.91 113.57 5.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.94 109.519 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mt -92.16 -20.64 21.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.93 109.44 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.11 176.07 41.38 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.486 -1.445 . . . . 0.43 109.486 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -1.141 . . . . 2.4 109.433 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.519 HD12 HD13 ' A' ' 55' ' ' ILE . 1.1 tp -93.75 146.13 24.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.96 109.459 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 77' ' ' GLU . 6.7 m -98.94 172.43 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 1.3 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' H ' HG22 ' A' ' 76' ' ' THR . 6.8 mt-10 -60.74 -168.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 2.62 109.473 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.97 103.37 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.576 -1.41 . . . . 2.26 109.576 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.502 -1.439 . . . . 4.08 109.502 179.999 . . . . . . . . 0 0 . 1 stop_ save_